Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | HTR2B | P41595 | 3/20 | 0.47 |
| ▸ | HTR7 | P34969 | 2/20 | 0.47 |
| ▸ | PNMT | P11086 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7937330 | 0.83 | RAB9A (0.51) | NPC1RAB9AHTR2BHTR7PNMT | |
| SCHEMBL2964568 | 0.82 | DRD2 (0.40) | NPC1RAB9AHTR2BHTR7DRD2 | |
| SCHEMBL2962510 | 0.82 | NPC1 (0.63) | NPC1RAB9AHTR2BHTR7HTR2C | |
| SCHEMBL30549083 | 0.81 | RAB9A (0.43) | NPC1RAB9AHTR2BHTR7PNMT | |
| SCHEMBL3491774 | 0.80 | NPC1 (0.59) | NPC1RAB9AHTR2BHTR7PNMT | |
| SCHEMBL26551302 | 0.79 | PNMT (0.46) | NPC1RAB9AHTR2BHTR7PNMT | |
| Ammonia Solution, Strong SCHEMBL27320939 | 0.79 | NPC1 (0.58) | NPC1RAB9AHTR2BHTR7PNMT | |
| Fluorene SCHEMBL28131122 | 0.79 | RAB9A (0.58) | NPC1RAB9AHTR2BHTR7PNMT | |
| SCHEMBL7796635 | 0.78 | RAB9A (0.50) | NPC1RAB9AHTR2BHTR7PNMT | |
| SCHEMBL1961388 | 0.76 | RAB9A (0.48) | NPC1RAB9AHTR2BHTR7PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3908680-B1 | METHODS FOR SCREENING INHIBITORS AGAINST CHIKUNGUNYA VIRUS AND FOR DETERMINING WHETHER SUBJECTS ARE PREDISPOSED TO INFECTION BY SAID VIRUS | INST NAT SANTE RECH MED (FR) | 2023-03-01 | — | — | EP | disclosed |
| CN-108490204-A | System and method for multiple analysis | 赛拉诺斯知识产权有限责任公司 | 2018-09-04 | — | — | CN | disclosed |
| CN-103946364-B | system and method for multiplex analysis | 赛拉诺斯知识产权有限责任公司 | 2018-04-24 | — | — | CN | disclosed |
| CN-105378450-A | System and method for multivariate analysis | THERANOS INC | 2016-03-02 | — | — | CN | disclosed |
| US-9029139-B2 | Omentum as a source of stromal/stem cells and medical treatment using stromal/stem cells | LOYOLA UNIVERSITY OF CHICAGO (US) | 2015-05-12 | — | — | US | disclosed |
| CN-101646418-B | Compositions and methods for modulating immune responses | UNIV QUEENSLAND | 2013-07-17 | — | — | CN | disclosed |
| US-20110081321-A1 | OMENTUM AS A SOURCE OF STROMAL/STEM CELLS AND MEDICAL TREATMENTS USING STROMAL/STEM CELLS | LOYOLA UNIVERSITY CHICAGO (US) | 2011-04-07 | — | — | US | disclosed |
| WO-2010111443-A2 | OMENTUM AS A SOURCE OF STROMAL/STEM CELLS AND MEDICAL TREATMENTS USING OMENTUM STROMAL/STEM CELLS | LOYOLA UNIVERSITY CHICAGO (US) | 2010-09-30 | — | — | WO | disclosed |
| CN-101646418-A | Compositions and methods for modulating immune responses | UNIV QUEENSLAND AU | 2010-02-10 | — | — | CN | disclosed |
| US-7378274-B2 | Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses | AVENTIS PHARMA S.A. (FR) | 2008-05-27 | — | — | US | disclosed |
| US-6475791-B1 | Uses for DNA structure-specific recognition protein | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2002-11-05 | — | — | US | disclosed |
| US-20020146792-A1 | Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses | AVENTIS PHARMA S.A. (FR) | 2002-10-10 | — | — | US | disclosed |
| WO-2001090408-A2 | METHOD FOR DETECTING AND CHARACTERISING ACTIVITY OF PROTEINS INVOLVED IN LESION AND DNA REPAIR | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2001-11-29 | — | — | WO | disclosed |
| US-5807672-A | DNA SEQUENCES, DIAGNOSING TUBERCULOSIS | INSTITUT PASTEUR (FR) | 1998-09-15 | — | — | US | disclosed |
| US-5705334-A | PREDICTING CYTOTOXICITY OF CANCER DRUGS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-01-06 | — | — | US | disclosed |
| EP-0490951-B1 | FRAGMENTS OF NUCLEIC ACIDS DERIVED FROM AN APPROPRIATE MYCOBACTERIA GENOME, THEIR APPLICATIONS IN THE DIAGNOSIS OF MYCOBATERIA INFECTIONS AND PLASMIDES CONTAINING SAID FRAGMENTS | PASTEUR INSTITUT (FR) | 1996-04-24 | — | — | EP | disclosed |
| WO-1991003558-A1 | FRAGMENTS OF NUCLEIC ACIDS DERIVED FROM AN APPROPRIATE MYCOBACTERIA GENOME, THEIR APPLICATIONS IN THE DIAGNOSIS OF MYCOBATERIA INFECTIONS AND PLASMIDES CONTAINING SAID FRAGMENTS | INSTITUT PASTEUR (FR) | 1991-03-21 | — | — | WO | disclosed |
| EP-0035549-A4 | DIFFUSION BIOASSAY FOR THE QUANTITATIVE DETERMINATION OF MUTAGENICITY. | MASSACHUSETTS INST TECHNOLOGY (US) | 1982-02-05 | — | — | EP | disclosed |
| EP-0035549-A1 | DIFFUSION BIOASSAY FOR THE QUANTITATIVE DETERMINATION OF MUTAGENICITY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-09-16 | — | — | EP | disclosed |
| WO-1981000726-A1 | DIFFUSION BIOASSAY FOR THE QUANTITATIVE DETERMINATION OF MUTAGENICITY | MASSACHUSETTS INST TECHNOLOGY (US) | 1981-03-19 | — | — | WO | disclosed |